BioNTech Provides Update on Phase 2/3 Clinical Trial for mRNA Cancer Immunotherapy Candidate BNT113 in Metastatic HPV16-positive Head and Neck Cancer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| (NASDAQ: BNTX) | Delayed: 91.29 +0.12 (0.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $91.17 | 52 Week High | $ | |||
| Open | $91.25 | 52 Week Low | $ | |||
| Day High | $92.35 | P/E | N/A | |||
| Day Low | $91.02 | EPS | $ | |||
| Volume | 1,113,487 | |||||
